EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Methotrexate and Prednisolone compared to placebo and prednisolone in the treatment of severe Erythema Nodosum Leprosum: An international multicentre, double-blind randomised controlled clinical trial—MaPs in ENL

Barbara de Barros iD, Farha Sultana, Neeta Maximus, Vivek V Pai, Anju Wakade, Bhagyashree Bhame, Bishwanath Acharya, Abdulnaser Hamza, Alemtsehay Getachew, Medhi Denisa Alinda, M Yulianto Listiawan, Shimelis N Doni und 10 weitere

PLOS Neglected Tropical Diseases · 2026

DOI: 10.1371/journal.pntd.0014739 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2026. Verfasst von Barbara de Barros und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Prednisolone, Methotrexate, Erythema Nodosum, Leprosy, Lepromatous. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Hospital and Homes of St. Giles, Leprosy Research Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Erythema nodosum leprosum (ENL) is a severe inflammatory complication of leprosy that often requires prolonged corticosteroid therapy which is associated with adverse effects. Methotrexate is an affordable immunomodulatory agent with limited evidence for its use in ENL treatment. We evaluated whether weekly oral methotrexate in addition to prednisolone reduces the need for additional prednisolone in adults with severe ENL. Methods and findings We performed an international, multicentre, double-blind, randomised, placebo-controlled trial conducted at five leprosy referral centres in Ethiopia, India, Indonesia, and Nepal. Adults aged 18–60 years with severe ENL were randomised to receive oral methotrexate (15mg, increased to 20mg in participants weighing ≥ 60 kg) for 48 weeks and prednisolone, or matching placebo and prednisolone. All participants received an identical 20-week prednisolone regimen, starting at 40mg daily, and were followed for 60 weeks. The primary outcome was time to first ENL flare requiring additional prednisolone, assessed over 24 and 48 weeks. Between January 2023 and June 2024, 231 individuals were screened and 137 were randomised (68 methotrexate and prednisolone; 69 placebo and prednisolone). By 24 weeks, 85/137 (62.0%) participants experienced an ENL flare requiring additional prednisolone; the adjusted hazard ratio (HR) for methotrexate versus placebo was 0.98 (95% CI 0.62–1.54). By 48 weeks, 102/137 (74.5%) experienced an ENL flare; adjusted HR 0.95 (95% CI 0.62–1.43). Secondary outcomes were similar: methotrexate did not reduce ENL severity at first flare, flare frequency, or severity of subsequent flares. Health-related quality of life improved substantially in both groups with no evidence of a differential treatment effect. Methotrexate was generally well tolerated. The trial was registered at ClinicalTrials.gov (NCT03775460).

Conclusions

Oral methotrexate added to prednisolone did not reduce the requirement for additional prednisolone or delay ENL flares compared to placebo and prednisolone, and our study does not support the use of methotrexate for severe ENL. Trial Registration ClinicalTrials.gov NCT03775460 registered on 29th November 2018.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PrednisoloneMethotrexateErythema NodosumLeprosy, LepromatousHumansAdultDouble-Blind MethodFemaleMaleMiddle AgedYoung AdultAdolescentTreatment OutcomeDrug Therapy, CombinationPlacebos

Substanzen

PrednisoloneMethotrexatePlacebos

Autor:innen und Institutionen

  • Department of Clinical Research, Faculty of Infectious & Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
  • The Leprosy Mission Trust India, New Delhi, India.
  • Bombay Leprosy Project, Mumbai, India.
  • Anandaban Hospital, The Leprosy Mission Nepal, Kathmandu, Nepal.
  • Department of Dermatology, ALERT Comprehensive Specialized Hospital, Addis Ababa, Ethiopia.
  • Department of Dermatology, Venereology & Aesthetic, Faculty of Medicine, Universitas Airlangga, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia.

ORCID-Profile: Barbara de Barros

Förderung

  • The Hospital and Homes of St. Giles
  • Leprosy Research Initiative

Zitieren

APA

de Barros, B., Sultana, F., Maximus, N., Pai, V. V., Wakade, A., Bhame, B., Acharya, B., Hamza, A., Getachew, A., Alinda, M. D., Listiawan, M. Y., Doni, S. N., Hagge, D. A., Napit, I., Shah, M., Darlong, J., Nicholls, P., Genser, B., Lambert, S. M., …, & Erythema Nodosum Leprosum International STudy (ENLIST) Group (2026). Methotrexate and Prednisolone compared to placebo and prednisolone in the treatment of severe Erythema Nodosum Leprosum: An international multicentre, double-blind randomised controlled clinical trial—MaPs in ENL. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0014739

Vancouver

de Barros B, Sultana F, Maximus N, Pai VV, Wakade A, Bhame B, et al. Methotrexate and Prednisolone compared to placebo and prednisolone in the treatment of severe Erythema Nodosum Leprosum: An international multicentre, double-blind randomised controlled clinical trial—MaPs in ENL. PLOS Neglected Tropical Diseases. 2026. doi:10.1371/journal.pntd.0014739

BibTeX
@article{deBarros2026,
  author = {de Barros, Barbara and Sultana, Farha and Maximus, Neeta and Pai, Vivek V and Wakade, Anju and Bhame, Bhagyashree and Acharya, Bishwanath and Hamza, Abdulnaser and Getachew, Alemtsehay and Alinda, Medhi Denisa and Listiawan, M Yulianto and Doni, Shimelis N and Hagge, Deanna A and Napit, Indra and Shah, Mahesh and Darlong, Joydeepa and Nicholls, Peter and Genser, Bernd and Lambert, Saba M and Lockwood, Diana N J and Walker, Stephen L and Erythema Nodosum Leprosum International STudy (ENLIST) Group, Erythema Nodosum Leprosum International STudy (ENLIST) Group},
  title = {Methotrexate and Prednisolone compared to placebo and prednisolone in the treatment of severe Erythema Nodosum Leprosum: An international multicentre, double-blind randomised controlled clinical trial—MaPs in ENL},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2026},
  doi = {10.1371/journal.pntd.0014739}
}
Kostenlos starten →